Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3927]
News [11457]
Articles [47]
Editorials [10]
Conferences [200]
elearning [4]
ASH 2023: Cell therapy appears safe and effective for lymphoma in remission
ASH 2023: Cell therapy appears safe and effective for lymphoma in remission
ASH 2023: Hodgkin lymphoma prognosis, biology tracked with circulating tumour DNA
ASH 2023: Hodgkin lymphoma prognosis, biology tracked with circulating tumour DNA
FDA approves enfortumab vedotin-ejfv with pembrolizumab for locally advanced or metastatic urothelial cancer
FDA approves enfortumab vedotin-ejfv with pembrolizumab for locally advanced or metastatic urothelial cancer
ASH 2023: New personalised therapy improves survival for patients with CLL leukaemia
ASH 2023: New personalised therapy improves survival for patients with CLL leukaemia
SABCS 2023: Model uses sociodemographic factors to predict aromatase inhibitor non-adherence risk
SABCS 2023: Model uses sociodemographic factors to predict aromatase inhibitor non-adherence risk
Fungus-fighting protein could help overcome severe autoimmune disease and cancer
Fungus-fighting protein could help overcome severe autoimmune disease and cancer
From resistance to resilience: Reprogramming drug resistant signals with artificial gene circuit device to overcome tumour chemotherapy challenges
From resistance to resilience: Reprogramming drug resistant signals with artificial gene circuit device to...
Protein implicated in tumour growth found to be heavily associated with pancreatic cancer
Protein implicated in tumour growth found to be heavily associated with pancreatic cancer
ASH 2023: Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma
ASH 2023: Combination immunotherapy produces high response rate in early results of trial targeting high-risk...
ASH 2023: Third-generation anti-CD19 CAR T-cells demonstrate efficacy without neurotoxicity in B-cell lymphoma phase 1 clinical trial
ASH 2023: Third-generation anti-CD19 CAR T-cells demonstrate efficacy without neurotoxicity in B-cell lymphoma...

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation